Allworth Financial’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-424
| Closed | -$53.9K | – | 4195 |
|
|
2024
Q4 | $53.9K | Buy |
424
+46
| +12% | +$5.85K | ﹤0.01% | 1534 |
|
|
2024
Q3 | $27.7K | Buy |
378
+5
| +1% | +$366 | ﹤0.01% | 1706 |
|
|
2024
Q2 | $27.9K | Buy |
373
+4
| +1% | +$299 | ﹤0.01% | 1667 |
|
|
2024
Q1 | $25.5K | Sell |
369
-14
| -4% | -$969 | ﹤0.01% | 1629 |
|
|
2023
Q4 | $27.4K | Buy |
383
+96
| +33% | +$6.88K | ﹤0.01% | 1463 |
|
|
2023
Q3 | $15K | Sell |
287
-380
| -57% | -$19.8K | ﹤0.01% | 1692 |
|
|
2023
Q2 | $42.2K | Buy |
667
+340
| +104% | +$21.5K | ﹤0.01% | 1175 |
|
|
2023
Q1 | $17.7K | Buy |
327
+25
| +8% | +$1.35K | ﹤0.01% | 1529 |
|
|
2022
Q4 | $16K | Buy |
302
+35
| +13% | +$1.85K | ﹤0.01% | 1484 |
|
|
2022
Q3 | $12K | Buy |
267
+265
| +13,250% | +$11.9K | ﹤0.01% | 1586 |
|
|
2022
Q2 | $0 | Sell |
2
-9
| -82% | – | ﹤0.01% | 2891 |
|
|
2022
Q1 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 2044 |
|